Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. BRZE
2. TTAN
3. AAPL
4. CHYM
5. USO
6. QCOM
7. IRT
8. ASO
9. LAES
10. UNFI

Go back to Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation
(NASDAQ: AXSM) Delayed: 209.57 +1.75 (0.84%)
Previous Close $207.82    52 Week High $15.74 
Open $207.97    52 Week Low $5.37 
Day High $211.17    P/E N/A 
Day Low $205.76    EPS $0.00 
Volume 210,226